The pharmacological management of severe acute and chronic pain frequently involves potent mu-opioid receptor agonists designed to alter nociceptive signal transmission within the central and peripheral nervous systems. Across international healthcare jurisdictions spanning the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, clinicians, researchers, and patients regularly […]